City of Hope

City of Hope is a National Cancer Institute-designated comprehensive cancer center for cancer, diabetes and other life-threatening diseases.

[City of Hope @cityofhope]

Congratulations to City of Hope's @christine_lovly on being named by @go2forlungcancr and @ALCMI_research as the 2026 recipient of the Bonnie J. Addario Lectureship Award. We're proud to celebrate this recognition and her commitment to advancing the future of cancer care.

[PETAL Consortium @mghpetal]

In this video, Dawn Diorio, RN, BSN, Clinical Research Nurse at @cityofhope, discusses the role of clinical research nurses in caring for patients with peripheral T-cell lymphoma (PTCL).

🌸 Full video: https://t.co/qkxv7wu91e

[Pashtoon Kasi MD, MS @pashtoonkasi]

👇🏽On @GMA; our patient and story! To more hope! 💡 For patients not only with pancreas #cancer, but the doors🚪open for other patients with cancers with the #KRAS mutation🧬and beyond.

🙏🏽 @CityofHope

📍@cityofhopeoc

https://t.co/v1fmS20NxG

[City of Hope @cityofhope]

Barbara Andes describes receiving #daraxonrasib, a promising treatment being studied for #pancreaticcancer, as a blessing. Through an expanded access program at @cityofhope, she's receiving a therapy that offers hope and reflects the promise of #cancer research.

[City of Hope @cityofhope]

You may never meet them. But they won’t forget how your words made them feel.

Call the City of Hope Line at [phone] to share a message of hope or hear from others who understand the weight of a cancer diagnosis.

#NationalCancerSurvivorsMonth

[City of Hope @cityofhope]

For someone facing cancer, a few words of encouragement can help carry the weight.

This #NationalCancerSurvivorsMonth, @marcroberge of O.A.R. is sharing a reminder of how much those words matter, especially on the hardest days.

Call the City of Hope Line at [phone].

[City of Hope @cityofhope]

After her father’s cancer diagnosis, Olympic snowboarder and @usskiteam member @hellobeakim saw firsthand the power of support.

Now, she invites you to call the City of Hope Line at [phone] to hear messages of hope or share one of your own. #NationalCancerSurvivorsMonth

[City of Hope @cityofhope]

Join us June 8, 5 to 6 p.m. PT for City of Hope's virtual GU Cancer Forum featuring key ASCO updates from our experts. Register: https://t.co/6N6WoV7nMP

[City of Hope @cityofhope]

At #ASCO26, Dr. Tanya Dorff (@TDorffOnc), division chief of GU oncology at @cityofhope, presented first-in-human data on a novel dual-targeted therapy with unprecedented results in metastatic castrate resistant prostate cancer.

[City of Hope @cityofhope]

What does it mean for @cityofhope to be at #ASCO26? Dr. Tycel Phillips (@LymphClinician), associate professor in the Division of Lymphoma, shares why having a presence at the largest cancer meeting in the world translates directly to better options and outcomes for patients.

[koral shah, md @kor_shah]

Our phase I trial now open @cityofhope evaluating the safety & efficacy of sodium thiosulfate in reducing cisplatin-induced ototoxicity in adults with metastatic testicular #GCT👂#ASCO26

Cisplatin remains highly curative, but ~75% of GCT survivors have audiometric hearing loss.

[Sumanta K. Pal, MD, FASCO @montypal]

It was a proud moment for me & my @cityofhope colleagues to see @christine_lovly grace the #ASCO26 plenary stage to give a wonderful discussion of the #LIBRETTO432 data. A crystal clear distillation of this complex trial, now published in @NEJM. @OncoAlert @StephenVLiu @PatelOncology

[ASCO @ASCO]

🎙 It's the final daily episode of #ASCO26! @montypal of @cityofhope provides his Top Takeaways on key Day 5 abstracts, available now on the #ASCODailyNews Podcast: https://t.co/8lCX8ZmNdc

[City of Hope @cityofhope]

Someone, somewhere, just heard the words, “you have cancer.” What would you say to them?

This #NationalCancerSurvivorsMonth, @cityofhope invites you to hear messages of hope or share one of your own. Call the City of Hope Line at [phone].

[Moffitt Cancer Center @MoffittNews]

Live from #ASCO26: Personalized medicine continues to reshape prostate cancer care. Tanya Dorff, MD (@cityofhope), reviews key advances helping clinicians better match treatments to each patient's disease and biology.

Key highlights:
• ADT + ARPI combinations continue to improve outcomes in high-risk prostate cancer.
• PROTEUS highlights the benefit of perioperative apalutamide.

• ARP inhibitors are moving into triplet regimens, with positive results from AMPLITUDE and TALAPRO-3.

• Radioligand therapies are expanding into new disease settings, including promising data for ^177Lu-PSMA and ^225Ac-PSMA.
• Key questions remain around treatment sequencing and patient selection.

#MoffittASCO26

[koral shah, md @kor_shah]

🚨Spectacular oral presentation at #ASCO26 from @RWinayak from @cityofhope on 1L CBM588 + ICI-based tx in mRCC showing improved outcomes in those w/ stool dysbiosis. Phase III BIOFRONT trial to further assess! @COHMedOnc @COHUroOnc @ASCOTECAG

[Salvador Jaime-Casas, MD @SalvadorjcMD]

⭐️ The one and only @RWinayak just delivered an outstanding oral presentation at #ASCO26 on microbial dysbiosis as a predictor of benefit from CBM588 in mRCC. This field is lucky to have him — can’t wait to see what’s next! 🙌

@cityofhope @CityofHope_GU

[City of Hope @cityofhope]

We’re proud to celebrate Dr. John Carpten, chief scientific officer at @cityofhope, on receiving the Allen Lichter Visionary Leader Award from @ASCO.

Through his leadership, City of Hope continues to push the boundaries of what’s possible for patients. #ASCO26

[City of Hope @cityofhope]

Dr. Pashtoon Kasi (@pashtoonkasi), medical director of GI oncology at @cityofhope Orange County, breaks down the latest advances in RAS-targeted therapies at #ASCO26 and what they mean for patients across pancreatic, colorectal, and lung cancer.

[City of Hope @cityofhope]

At #ASCO26, Dr. Kristin Higgins (@KHigginsMD), chief clinical officer at City of Hope Atlanta, moderated a multidisciplinary panel on ALK-mutated non-small cell lung cancer and shares what makes City of Hope's national footprint unlike any other.